Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Dermatitis ; 32(1): 5-9, 2021.
Article in English | MEDLINE | ID: covidwho-1272982

ABSTRACT

Acetophenone azine (CAS 729-43-1) was recently discovered as a potent allergen in shin pads and footwear containing the foam elastomer ethyl vinyl acetate. The compound is probably not intentionally added to ethyl vinyl acetate but is likely the result of reactions between other additives that take place during the manufacturing process. A patch testing concentration of 0.1% in acetone or petrolatum is recommended. Acetophenone azine should be part of patch testing shoe series, as well as plastics and glues series. The compound is not currently available from patch testing materials suppliers, a situation that hopefully will be corrected.


Subject(s)
Allergens , Dermatitis, Allergic Contact/etiology , Hydrazines/adverse effects , Imines/adverse effects , Protective Devices , Shoes , Sports Equipment , Humans , Vinyl Compounds
2.
BMJ Case Rep ; 14(4)2021 Apr 07.
Article in English | MEDLINE | ID: covidwho-1172743

ABSTRACT

A 77-year-old man was admitted with severe acute kidney injury and nephrotic syndrome. He was started on eltrombopag for chronic idiopathic thrombocytopenic purpura 6 weeks earlier. An ultrasound of the kidneys was normal and an auto-antibody screen was negative. The use of the Naranjo adverse drug reaction probability scale indicated a probable relationship (score of 5) between the patient's development of acute renal failure and eltrombopag therapy. Literature review identified only one other case of nephrotic syndrome and acute kidney injury associated with eltrombopag therapy in which a kidney biopsy revealed focal segmental glomerulosclerosis. Due to the challenges faced during the prevailing SARS-CoV-2 pandemic and persistent low platelet counts a renal biopsy was not undertaken. On stopping eltrombopag, the patients renal function stabilised and he successfully went into remission following treatment with high dose corticosteroids and diuretics. This report of a serious case of reversible renal failure and nephrotic syndrome after treatment with eltrombopag may serve to inform clinicians about the possible severe renal adverse effects of eltrombopag before its commencement for future use.


Subject(s)
Acute Kidney Injury/chemically induced , Benzoates/adverse effects , Hydrazines/adverse effects , Nephrotic Syndrome/chemically induced , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Pyrazoles/adverse effects , Adrenal Cortex Hormones/therapeutic use , Aged , Humans , Kidney/drug effects , Male
SELECTION OF CITATIONS
SEARCH DETAIL